U.S. cardiovascular company IPO financing volume 2006-2023
Illustrated is the amount of money which emerging therapeutic companies in the U.S. cardiovascular disease and disorders segment raised through initial public offerings from 2006 to 2023. In 2023, such companies in the U.S. raised 192 million dollars by going public.